Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
06/13/2002 | DE10041671C1 Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung Benzodiazepines process for the preparation of imidazo [1,2-c] [2,3] oxazole and phenylacetic acid esters and derivatives, as intermediates in the preparation thereof |
06/13/2002 | CA2436916A1 Use of pyrazolo[4,3-d]pyrimidines |
06/13/2002 | CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
06/13/2002 | CA2431187A1 Macroheterocylic compounds useful as kinase inhibitors |
06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
06/13/2002 | CA2429728A1 Tyrosine kinase inhibitors |
06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
06/12/2002 | EP1212384A1 Selectively light-absorptive material, coating composition containing the same, and filter manufactured using the coating composition for color displays |
06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
06/12/2002 | EP1212326A1 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
06/12/2002 | EP1212325A2 A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
06/12/2002 | EP1212324A1 Imidazo-triazine derivatives as ligands for gaba receptors |
06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
06/12/2002 | EP1211940A1 Azabicyclo and azacyclo oxime and amine compounds as pesticides |
06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
06/12/2002 | EP0888354B1 Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same |
06/12/2002 | EP0885221B1 Azabicyclic esters of carbamic acids useful in therapy |
06/12/2002 | CN1353714A Triazolopyrimidinol compounds and salts thereof |
06/12/2002 | CN1353702A Adamantane derivatives |
06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
06/12/2002 | CN1353606A IL-8 receptor antagonists |
06/11/2002 | US6403807 Bridged fluorescent dyes, their preparation and their use in assays |
06/11/2002 | US6403790 Suspending and dissolving epinastine base in water by adding aqueous hydrochloric acid at specified ph, extracting solution obtained with organic water-immiscible solvent, removing solvent, adjusting ph to precipitate product, drying |
06/11/2002 | US6403788 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
06/11/2002 | US6403632 Cyclic amide derivative |
06/11/2002 | US6403608 3-Substituted isoquinolin-1-yl derivatives |
06/11/2002 | US6403592 Serotonin reuptake inhibitors |
06/11/2002 | US6403591 1-azatricyclic-4-benzylpiperazines |
06/11/2002 | US6403588 Imidazopyridine derivatives |
06/11/2002 | CA2169838C Antipsychotic method |
06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
06/06/2002 | WO2002044182A1 Condensed purine derivatives as a1 adenosine receptor antagonists |
06/06/2002 | WO2002044180A1 Lactam compounds and medicinal use thereof |
06/06/2002 | WO2002044179A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
06/06/2002 | WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
06/06/2002 | US20020068827 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists |
06/06/2002 | US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof |
06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
06/06/2002 | US20020068744 Interacting with tubulin and microtubules and promoting microtubule polymerization |
06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
06/06/2002 | US20020068721 Purine derivatives |
06/06/2002 | US20020068705 Sugar derivatives of indolocarbazoles; exhibit topoisomerase-I activity |
06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
06/06/2002 | CA2425892A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivative or salt thereof |
06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
06/05/2002 | EP1210714A2 High density non-volatile memory device |
06/05/2002 | EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES |
06/05/2002 | EP1210333A2 Novel herbicides |
06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
06/05/2002 | EP0642516B1 Macrocyclic immunomodulators |
06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
06/04/2002 | US6399785 Multiply-substituted fullerenes |
06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
06/04/2002 | US6399769 Reacting formylbenzenesulfonic acid and pyrrole; heating |
06/04/2002 | US6399768 Recording |
06/04/2002 | US6399621 N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
06/04/2002 | US6399609 Corticotropin releasing factor (crf) antagonists |
06/04/2002 | US6399608 Fluoxetine, paroxetine or sertraline with 1,2,4-triazolo (4,3-b)pyridazine derivative; nonsedating anxiolytic modulator of benzodiazepine binding site of gamma amino-butyric acid receptor; central nervous system |
06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
06/04/2002 | US6399597 1,8-naphthosultamylmethyl carbapenem antibacterial compounds, compositions containing such compounds and methods treatment |
05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
05/30/2002 | WO2002042305A1 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition |
05/30/2002 | WO2002042304A2 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists |
05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
05/30/2002 | WO2002041880A2 Use of pyrazolo[4,3-d]pyrimidines |
05/30/2002 | WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
05/30/2002 | WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
05/30/2002 | WO2001046194A3 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives |
05/30/2002 | US20020065416 Anti-inflammatory agents |
05/30/2002 | US20020065414 Quarternary ammonium salt can act as phase-transfer catalyst to convert glycine derivatives into optically active alpha-amino acid derivatives by stereoselectively alkylating glycine derivatives |
05/30/2002 | US20020065309 For therapy of sex-hormone related conditions, as contraceptives |
05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
05/30/2002 | US20020065291 Amine salts of an integrin receptor antagonist |
05/30/2002 | US20020065290 Used as corticotropin-releasing factor (CRF) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (PTSD) as well as depression, headache and anxiety |
05/30/2002 | US20020065284 Dipeptide derivatives |
05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
05/30/2002 | US20020065248 Pyrrolopyrazinones useful as serine protease inhibitors |
05/30/2002 | CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines |
05/29/2002 | EP1208748A1 Organ preservatives |
05/29/2002 | EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
05/29/2002 | EP1208102A1 Synthesis of substituted pyrazolopyrimidines |
05/29/2002 | EP1084148A4 A catalyst that oxidizes steroids and other substrates with catalytic turnover |
05/29/2002 | DE10058662A1 Verwendung von Pyrazolo[4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
05/29/2002 | CN1351498A Pyrrolotriazines inhibitors of kinases |
05/29/2002 | CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors |
05/29/2002 | CN1351014A Process for preparing chlorophyll zinc and its product |
05/29/2002 | CN1351012A Process for extracting high-purity tea polyphenol, theapigment and theine |
05/29/2002 | CN1085710C Structured pigment coating and its preparation and use |
05/28/2002 | US6395810 Bicyclooctane derivatives as plasticizers |
05/28/2002 | US6395809 Salt formation with hydrochloric, sulfuric, or phosphoric acid; automobiles, electronics |